Teri Lawver is the Global Commercial Strategy Leader, Global Vice President, for the Immunology Therapeutic Area with Janssen Pharmaceutical Companies of Johnson & Johnson.Teri has more than 20 years of global healthcare and business leadership experience spanning three continents, three healthcare sectors, and dozens of disease areas. She has a proven track record in building new businesses, delivering sustainable, innovation-based growth, and developing high-performance teams
Immunology